Prenetics Global LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Genetel Bioventures Limited and Michael Yang Mengsu report beneficial ownership of 3.3% of Prenetics Global Ltd's Class A Ordinary Shares as of March 31, 2026.